Form 4 for ONC BeOne Medicines Ltd.
Accepted 2026-08-03 17:18:28 ET · period of report 2026-07-30 · accession 0001980648-26-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-03 17:18 | 2026-07-30 | ONC | Lee Chan Henry | SVP, GC | S - Sale | $323.69 | -1,044 | 0 | -100% | -$337.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2026-07-30 | S | D | 1,044 | $323.69 | 0 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. (F2) The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 29, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. |